Last updated on August 2017

A Multicenter, Randomized, Investigator- and Subject-Blind, Placebo-Controlled, Treatment Sequence Study Evaluating the Safety, Tolerability, and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis


Brief description of study

A Multicenter, Randomized, Investigator- and Subject-Blind, Placebo-Controlled, Treatment Sequence Study Evaluating the Safety, Tolerability, and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis

Detailed Study Description

The purpose of the study is to evaluate the clinical efficacy of UCB7665 as an chronic-intermittent treatment in subjects with generalized myasthenia gravis (MG) who are classified as moderate to severe.

Clinical Study Identifier: TX152097

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Brittany Harvey

University of South Florida - Morsani Center for Advanced Healthcare
Tampa, FL USA
  Connect »